The Lower-Risk Cannabis Use Guidelines' (LRCUG) recommendations: How are Canadian cannabis users complying?

Behavior Canada Cannabis Evaluation Guidelines Health Prevention Risk Behavior

Journal

Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 16 08 2020
accepted: 19 08 2020
entrez: 21 10 2020
pubmed: 22 10 2020
medline: 22 10 2020
Statut: epublish

Résumé

Canada, alongside other jurisdictions, implemented non-medical cannabis legalization in 2018, partly towards improving public health. Evidence-based 'Lower-Risk Cannabis Use Guidelines' (LRCUG), including recommendations for cannabis users on how to decrease risk-behaviors for harms, have been developed and widely disseminated in Canada since 2017. However, knowledge on users' compliance with the LRCUG is limited. We identified four major Canadian (three national, one provincial) population surveys presenting key data on cannabis-related behaviors: the National Cannabis Survey, Canadian Cannabis Survey, Canadian Tobacco, Alcohol & Drugs Survey, and CAMH Monitor. We scanned each survey for indicator data mapping onto either of the LRCUG's recommendations for the years 2017 to 2019. Relevant indicator data, albeit with varying operationalizations, were found for six of the ten LRCUG's recommendation clusters in at least some of the surveys, and were extracted and summarized. For results, substantial -- but declining -- majorities of users consumed cannabis by smoking, yet with shifts towards other use modes. Between one- to two-in-five users engaged in the risk-behaviors of using high-potency cannabis products, frequent cannabis use and cannabis-impaired driving, respectively. A small proportion of pregnant or breastfeeding women continued cannabis use during the study period. The data identified found suggested a heterogeneous picture regarding cannabis users' compliance with the LRCUG's recommendations. Non-compliance is highest for recommendations regarding modes-of-use, and applies to minorities of users for other risks factors. These sub-groups are at elevated risk for acute (e.g., accidents) or long-term (e.g., dependence) cannabis-related harms contributing to the public health burden. Appropriate targeted interventions in these areas require improvement.

Identifiants

pubmed: 33083205
doi: 10.1016/j.pmedr.2020.101187
pii: S2211-3355(20)30146-7
pmc: PMC7554648
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101187

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

JAMA Psychiatry. 2016 Mar;73(3):292-7
pubmed: 26842658
Curr Pharm Des. 2014;20(25):4112-8
pubmed: 24001294
Obstet Gynecol. 2012 Mar;119(3):603-10
pubmed: 22314872
Am J Addict. 2014 May-Jun;23(3):234-42
pubmed: 24724880
Drug Alcohol Depend. 2006 Mar 15;82(1):1-9
pubmed: 16183213
PLoS One. 2016 Jan 22;11(1):e0146853
pubmed: 26800209
Addiction. 2017 Dec;112(12):2167-2177
pubmed: 28556310
Int J Drug Policy. 2020 Feb;76:102658
pubmed: 31927413
Pediatrics. 2018 Aug 27;:
pubmed: 30150211
J Midwifery Womens Health. 2009 Nov-Dec;54(6):430-44
pubmed: 19879515
Lancet. 2019 Oct 26;394(10208):1580-1590
pubmed: 31657733
J Community Health. 2017 Apr;42(2):278-286
pubmed: 27639866
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):73-86
pubmed: 30604051
PLoS One. 2013 Oct 24;8(10):e76635
pubmed: 24204649
Addiction. 2016 Apr;111(4):653-62
pubmed: 26598973
Health Rep. 2019 Jun 19;30(6):3-13
pubmed: 31216047
Lancet. 2004 May 15;363(9421):1579-88
pubmed: 15145631
Drug Test Anal. 2014 Jan-Feb;6(1-2):39-45
pubmed: 23836598
Curr Addict Rep. 2017;4(4):343-349
pubmed: 29201592
Lancet. 2012 Jan 7;379(9810):55-70
pubmed: 22225671
Int J Drug Policy. 2019 Jul 25;:102509
pubmed: 31351756
Int J Drug Policy. 2016 Aug;34:1-4
pubmed: 27198553
Int J Drug Policy. 2019 Jun;68:132-138
pubmed: 30025898
Am J Public Health. 2017 Aug;107(8):e1-e12
pubmed: 28644037
Obstet Gynecol Surv. 2019 Jul;74(7):415-428
pubmed: 31343707
Circulation. 2016 Jan 12;133(2):187-225
pubmed: 26746178
J Occup Rehabil. 2004 Dec;14(4):243-53
pubmed: 15638255
BMC Public Health. 2012 Sep 07;12:751
pubmed: 22958371
Arch Pediatr Adolesc Med. 2003 Apr;157(4):381-8
pubmed: 12695235
Int J Drug Policy. 2016 Oct;36:141-7
pubmed: 26992484
Curr Opin Psychol. 2019 Dec;30:98-102
pubmed: 31071592
Can J Psychiatry. 2019 Feb;64(2):82-87
pubmed: 30033757
Am J Prev Med. 2017 Feb;52(2):e33-e66
pubmed: 27914771
Drug Alcohol Rev. 2012 Mar;31(2):141-50
pubmed: 21954858
J Am Diet Assoc. 2008 Mar;108(3):553-61
pubmed: 18401922
Ann Intern Med. 2018 Dec 18;169(12):890-892
pubmed: 30167665
Int J Drug Policy. 2018 Feb;52:87-96
pubmed: 29277082
JAMA Psychiatry. 2018 Jun 1;75(6):585-595
pubmed: 29710074
JAMA Pediatr. 2019 Jun 17;:
pubmed: 31206147
CMAJ. 2018 Sep 4;190(35):E1031-E1032
pubmed: 30181148
J Adolesc Health. 2019 Apr;64(4):487-493
pubmed: 30205931
J Public Health (Oxf). 2016 Mar;38(1):183-8
pubmed: 25630540
Can J Public Health. 2019 Aug;110(4):472-475
pubmed: 31087281
Lancet Public Health. 2017 Dec;2(12):e536-e537
pubmed: 29253435
Am J Drug Alcohol Abuse. 2019;45(6):689-697
pubmed: 31135218
Int J Drug Policy. 2020 Feb 26;77:102698
pubmed: 32113149
Implement Sci. 2012 Jul 25;7:70
pubmed: 22831550
BMJ. 2012 Feb 09;344:e536
pubmed: 22323502
Ann Behav Med. 2004 Feb;27(1):3-12
pubmed: 14979858
Can J Public Health. 2011 Sep-Oct;102(5):324-7
pubmed: 22032094
Int J Drug Policy. 2014 Mar;25(2):308-19
pubmed: 24502887
Int Rev Psychiatry. 2020 May;32(3):221-234
pubmed: 32026735
N Engl J Med. 2014 Jun 5;370(23):2219-27
pubmed: 24897085
Drug Alcohol Rev. 2010 May;29(3):318-30
pubmed: 20565525
Addiction. 2016 Oct;111(10):1764-73
pubmed: 27082374
Int J Environ Res Public Health. 2019 Oct 25;16(21):
pubmed: 31731420
Am J Public Health. 2020 Jan;110(1):71-72
pubmed: 31800288
Am J Prev Med. 2016 Jan;50(1):1-8
pubmed: 26277652
J Public Health (Oxf). 2019 Jun 1;41(2):412-421
pubmed: 29860521
Accid Anal Prev. 2013 Nov;60:254-67
pubmed: 22785089
Int J Drug Policy. 2014 Jul;25(4):727-35
pubmed: 24970383
BMJ Open. 2016 Apr 05;6(4):e009986
pubmed: 27048634
Lancet Child Adolesc Health. 2019 Feb;3(2):121-128
pubmed: 30573419
Accid Anal Prev. 2013 Jan;50:879-86
pubmed: 22871272
Drug Alcohol Rev. 2012 Mar;31(2):156-61
pubmed: 22150871
Drug Alcohol Rev. 2012 Mar;31(2):206-12
pubmed: 22050096
Int J Drug Policy. 2017 Apr;42:57-62
pubmed: 27908654
Int J Environ Res Public Health. 2017 Apr 05;14(4):
pubmed: 28379177
J Addict Med. 2011 Mar;5(1):1-8
pubmed: 21321675
Addiction. 2015 Jan;110(1):19-35
pubmed: 25287883
Addiction. 2016 Aug;111(8):1348-59
pubmed: 26878835

Auteurs

Chae-Rim Lee (CR)

Centre for Applied Research in Mental Health & Addiction, Faculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada.

Angelica Lee (A)

Centre for Applied Research in Mental Health & Addiction, Faculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada.

Samantha Goodman (S)

School of Public Health & Health Systems, University of Waterloo, Waterloo, ON, Canada.

David Hammond (D)

Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Benedikt Fischer (B)

Centre for Applied Research in Mental Health & Addiction, Faculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada.
Schools of Population Health and Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.

Classifications MeSH